Cell cycle control in cellular homeostasis during the immune response: Interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 1, 2001, Pages 63-71

  Contasta, I ^a   Pellegrini, P ^a   Berghella, A M ^a   Adorno, D ^a  

^a Istituto Tipizzazione Tissutale L'Aquila   (Italy)

Author keywords

Cellular homeostasis, Bcl2, p53, cytokine network, TH1, TH2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN ANTIBODY; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL SURVIVAL; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE; MALE; NORMAL HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; TH1 CELL; TH2 CELL;

EID: 0035087782     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497801750096069     Document Type: Article

References (39)

1. BCL-2 family: Regulators of cell death
2. Regulation of lymphocyte survival by the bcl-2 gene family
3. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
4. The Bcl-2 protein family: Arbiters of cell survival
5. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
6. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival
7. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation
8. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2
9. Calcineurin functions in Ca(2+)-activated cell death in mammalian cells
10. The development of functionally responsive T cells
11. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation
12. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes
13. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
14. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect
15. p53-dependent apoptosis suppresses tumor growth and progression in vivo
16. Revisiting and revising suppressor T cells
17. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells
18. TH1 and TH2 cell antigen receptors in experimental leishmaniasis
19. A common precursor for CD4+ T cells producing IL-2 or IL-4
20. Cytokines in inflammatory bowel disease
21. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo
22. IL-4 is a major determinant of T cell lymphokine-producing phenotype
23. Selective differentiation of CD4+ T helper cell subsets
24. Helper T-cell subsets: Phenotype, function and the role of lymphokines in regulating their development
25. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12
26. IL-2 deprivation triggers apoptosis which is mediated by c-Jun N-terminal kinase 1 activation and prevented by Bcl-2
27. Interleukin-10 rescues T cells from apoptotic cell death: Association with an upregulation of Bcl-2
28. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis
29. Interleukin-2 receptor common gammachain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression
30. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression
31. Optimal proliferation of a hematopoietic progenitor cell line requires either costimulation with stem cell factor or increase of receptor expression that can be replaced by overexpression of Bcl-2
32. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation
33. Progression mechanisms in colon cancer: Soluble interleukin-2(IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations
34. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
35. Inactivation of IkappaB-beta by the tax protein of human T-cell leukemia virus type 1: A potential mechanism for constitutive induction of NF-kappaB
36. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha
37. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells
38. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
39. Suppression of TNF-alpha-induced apoptosis by NF-kappaB